News

EN

[Project Announcement] NKCL Project direction: NKCLM Burning FILE

Hello. This is NKCL Bio Group Inc.1. Creating NKCLM EcosystemThe immune care products of NKCL Platform is only available in NKCLM, to strengthen the token economy. 2. NKCLM BurningIn order to stabilize the NKCLM’s market price, NKCLM burning will take place as promised. A part of foundatio...

NKCL | 2020.08.11 | 조회 3

NKCL Bio Group to launch ‘NK Cordycep Gold 300’ – the immunity boosting functional food FILE

Followed by ‘NK Blue Bio Series’, NKCL Bio Group launched ‘NK Cordycep Gold 300’, the anti-cancer and immunity enhancement functional food. ‘NK Cordycep Gold 300’ is a rice powder in which cordycepin is grown within the rice. Cordycepin is a major ingredient of Cordyceps Millit...

NKCL | 2020.06.16 | 조회 69

NKCL Bio Group Inc. launched NK Blue Bio Series (Blue Recombination Cream & Peel Mask) FILE

NKCL Bio Group has launched and started the sales of NK Blue Bio Cream that is effective on solving various skin problems. NK Blue Bio Series is composed with Blue Recombination Cream and Peel Mask and it is different from conventional cosmetic products. Normally the dead skin cells...

NKCL | 2020.06.11 | 조회 71

NKCL Bio Group had relocated the head office to Dongtan, Korea on May 28th, 2020 FILE

Construction site on May 9th Despite the delay in acquiring materials due to COVID-19 crisis, the construction went smoothly according to the plan. NKCL's GMP authorized Automated NK Cell Cultivation Center will not only act as a research and development, but also carry out o...

NKCL | 2020.06.04 | 조회 69

NKCL Bio Group will restart its Global Marketing! FILE

NKCL Bio Group will restart its Global Marketing!Due to COVID-19 pandemic, which has upended economies and wreaked havoc on nearly every country across the globe, NKCL had to temporarily stop its global marketing plans.However, on May 21 (Thu), 2020, NKCL will hold a business seminar in its Shenzhen ...

NKCL | 2020.05.19 | 조회 84

[Construction of Automated NK Cell cultivation system is progressing smoothly] FILE

Despite the delay due to not enough supply of the materials caused by COVID-19 crisis, the construction of ‘NK Cell GMP Automated Cultivation System’ is running smoothly according to the schedule. We share some of the footages of the construction site. NKCL Bio Group’s A...

NKCL | 2020.05.07 | 조회 93

NKCL Bio Group signed MOA with Labelle Clinic of Gwang-ju, Korea, regarding NK Cell Treatment FILE

NKCL Bio Group and Labelle Clinic of Gwang-ju, Korea, had signed MOA on April 28th, agreeing upon delivering NK cell treatment. Labelle Clinic has 4 storied building with organized facilities. With director Park Tae-ho, many medical professionals and staff members...

NKCL | 2020.05.07 | 조회 61

NKCL Bio Group Launches ‘NK Rest Brain’ that gives 3-hour deep sleep effect by 30-minute rest program FILE

  NKCL Bio Group Inc. (hereinafter referred to as ‘NKCL Bio Group’) is a Korean Bio Group company that researches and develops NK Immune cell treatment which utilizes NK immune cells. With its competitive technologies including cancer cell target treatment and Automatic NK Cell Cultivatio...

NKCL | 2020.04.27 | 조회 61

NKCL Bio Group Inc. expands its infrastructure of domestic hospitals. FILE

  NKCL Bio group Inc. (hereinafter referred to as NKCL Bio Group) is a Korean bio company that researches and develops NK immune cell treatment using NK immune cell with its competitive technology. Last year, it had laid the foundation for popularizing NK immune cell treatment by opening th...

NKCL | 2020.04.06 | 조회 95

NKCL Bio Group will culturally promote its brand with Bold Film, the maker of the movie ‘Whiplash’. FILE

  Richard Walters, the producer of Bold Films (Left) and Shin Dong-Hwa, the chairman of NKCL Bio Group (Right) NKCL Bio Group Inc. (Hereinafter referred to as ‘NKCL Bio Group’) is Korean bio-enterprise that researches and develops Immune Cell Treatment that utilizes NK Immune Cells...

NKCL | 2020.02.27 | 조회 38
[ 1 ] 2 3 4

NKCL     |     info@nkcl.io
ⓒ 2019 NKCL All rights reserved.